Niron Magnetics CEO Testifies Before Congress on Urgent Action Needed for Rare Earth Alternatives
Jonathan Rowntree, Chief Executive Officer of Niron Magnetics, testified Wednesday before the U.S. House Select Committee on the Chinese CCP, presenting the company’s breakthrough Iron Nitride magnet technology as a solution to reducing America’s critical dependence on rare earth materials.
Medcrypt Achieves 100% FDA Submission Approval Rate and Launches Security Intelligence to Help Mature Medical Device Cybersecurity Program
Medcrypt Inc., the leader in medical device cybersecurity, today announced the launch of Medcrypt Security Intelligence, the industry’s first expert-enhanced software solution for assessing, benchmarking, and advancing cybersecurity program maturity across the medical device lifecycle.
Niron Magnetics Expands Board of Directors with Seasoned Technology and Finance Experts to Lead the Next Chapter of Growth
Niron Magnetics, the company manufacturing high-performance Iron Nitride permanent magnets made without rare earths, announced the appointment of Jon Olson and Eric Stang to its Board of Directors. Their deep experience in technology, finance, and scaling high-growth public and private companies will help guide Niron Magnetics’ journey as it expands manufacturing, commercial operations, and global partnerships in preparation for future growth.
ExOne and voxeljet Launch Unified Global Aftermarket Support Network across Eight Countries and more than 45 factory-trained technicians
ExOne GmbH and voxeljet AG, both members of ExOne Global Holdings, today announced the launch of a joint global Aftermarket Service and Support Network for their industrial 3D printing systems. The collaboration brings together two of the most experienced teams in binder jet 3D printing under one coordinated service framework, designed to deliver faster response times, higher uptime, and greater customer confidence.
LG Energy Solution to Enter Aerospace Battery Sector in Partnership with South8 Technologies
LG Energy Solution today announced a strategic partnership with South 8 Technologies to jointly develop space-rated lithium-ion batteries optimized for extreme low temperatures. This agreement positions LG Energy Solution to participate in the development of next-generation battery technologies that can withstand harshest environments, establishing a foothold in the emerging aerospace sector.
Galvion and South 8 Technologies Sign Letter of Intent to Collaborate on Lithium-ion Battery Technology for Extreme Cold Environments
South 8 Technologies, a San Diego–based innovator redefining lithium-ion battery performance with its patented LiGas® cell technology, today announced it has signed a Letter of Intent (LOI) with Galvion, a global leader in the design and manufacture of intelligent power and data management solutions, innovative head systems and integrated soldier systems. The LOI represents a shared commitment between two innovative defense and energy organizations to push the boundaries of battery performance through focused research and product development.
Cue Biopharma and ImmunoScape Announce Strategic Collaboration to Develop Breakthrough Cell Therapy Approach for Solid Tumors
Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells for the treatment of autoimmune disease and cancer, and ImmunoScape, Pte. Ltd, a biotechnology company developing next-generation T cell receptor (TCR)-based therapies in oncology, today announced that they have entered into a collaboration and license agreement to advance a novel in vivo approach to cell therapy for the treatment of solid tumors. Under the agreement, ImmunoScape will develop a novel Seed-and-Boost immunotherapy that combines Cue Biopharma’s clinically-validated Immuno-STAT T-cell engagers, the CUE-100 series, with ImmunoScape’s proprietary TCRs. The combination therapy is designed to overcome core limitations of existing cell therapies with the potential for establishing a breakthrough standard of care with superior anti-tumor activity, durable T cell persistence and product scalability.
Niron Magnetics and City of Sartell Advance Next Phase of Rare-Earth-Free Permanent Magnet Manufacturing Project
Niron Magnetics, the company manufacturing high-performance Iron Nitride permanent magnets made without rare earths, announced an expanded partnership with the City of Sartell to build the company’s first full-scale production facility. This collaboration builds on prior agreements, including the purchase of 79 acres of land in Sartell’s Mill District, and marks a major step in Niron Magnetics’ expansion and the community’s economic development.
Tier-One OEMs and Cell Manufacturers Validate AMB’s Powder to Electrode™ Technology at Live Production Demo
AM Batteries (AMB) demonstrated commercial-scale dry electrode manufacturing using its proprietary dry deposition method to over 70 industry leaders during Demo Day, proving the technology delivers the cost savings and performance needed to accelerate EV adoption and strengthen domestic battery manufacturing.
Thirdwayv and Medcrypt Forge Partnership to Advance Medical Device Cybersecurity and Interoperability
Thirdwayv Inc., a leader in secure software solutions for connected medical devices, and Medcrypt Inc., a premier provider of medical device cybersecurity and vulnerability management solutions, announced today at the Diabetes Technology Society Conference, DTM 2025, the signing of an agreement to jointly advance cybersecurity and interoperability standards and solutions across the connected medical device ecosystem.